Open access
Sep 2026
Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine in China: A Phase IV Study
The aim of this work is to preliminarily evaluate the post-marketing safety of a quadrivalent subunit influenza vaccine in healthy individuals aged 3 years and above through active surveillance of adverse reactions following vaccination. During the 2024–2025 influenza season, healthy participants aged 3 years and older...
Liu-Yang Kang, Ming-Wei Wei, Hui Jiang et al.
· Infectious Disease and Thera... · 0 citations